Former FDA chief Gottlieb explains the potential of Gilead's Covid-19 treatment

Reports that Gilead's drug Remdesivir is reportedly showing effectiveness in treating coronavirus sent the stock higher ahead of Friday's open. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins "Squawk Box" to discuss.
Fri, Apr 17 20206:44 AM EDT